对体外受精培养液成分不可容忍的无知
该文指出体外受精培养液对成功率至关重要,其成分在路易丝·布朗出生后45年间历经重大修改;目前多数项目依赖市售培养液,但因厂商主张配方 proprietary,产品标签不再提供成分及浓度信息;作者认为这不应成为公司秘密,呼吁临床医生和科学家坚持要求标签列出全部成分及浓度。
要点
- 培养液在体外受精成功中起重要作用,其成分45年来历经重大修改。
- 多数体外受精项目依赖市售培养液,但成分及浓度信息已无法获得。
- 作者呼吁培养液标签应列出全部成分及浓度,以监测其对结局的影响。
核心结论
- 培养液成分信息不应成为公司秘密,临床医生和科学家应坚持要求标签列出全部成分及浓度。
- 只有这样才能监测培养液对体外受精结局的影响、创新并继续推进该领域。
研究设计与样本
- 原文为观点性文章,未报告系统检索范围或研究方法。
主要发现
- 自路易丝·布朗出生后45年间,培养液成分历经重大修改。
- 多数体外受精项目依赖小瓶装市售培养液,保证无菌且无胚胎毒性。
- 厂商以配方 proprietary 为由,产品标签不再提供成分及浓度信息。
临床怎么用
- 作者认为,体外受精领域的临床医生和科学家必须坚持要求培养液标签包含全部成分及其浓度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Culture media play an essential role in the success of IVF. Their composition has undergone major modifications over the 45 years since the birth of Louise Brown. Most IVF programmes now rely on commercially produced media, which they buy in small vials, guaranteed to be sterile and non-embryotoxic. Unfortunately, information about the components of the culture media and their concentrations is no longer available. Arguing that culture media recipes are proprietary, relevant commercial interests have stopped labelling their products with this vital information. Given the critical role that is played by culture media in the success of IVF, as well as the subsequent health of the children who are born after IVF, this information should not remain a 'company secret'. Clinicians and scientists working in IVF must insist that the labelling of culture media includes all of the constituents and their concentrations. Only in this way can we monitor the influence of culture media on IVF outcomes, innovate and continue to advance the field of IVF.
引用
- Paulson RJ, Adashi EY. The unbearable ignorance of the composition of IVF culture media. Reprod Biomed Online. 2023. PMID: 38228053. doi:10.1016/j.rbmo.2023.103645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。